CD19 is a cell-surface component of the B-cell receptor complex involved in B-cell activation, which expressed at high and stable levels on tumor tissue from most patients with-B cell acute lymphoblastic leukemia (B-ALL), non-Hodgkin's lymphoma (NHL), and chronic lymphocytic leukemia (CLL). Here, CD19 is linked to neoplasm.